- General information enquiries
- Call 00 800 6 7 8 9 10 11
- E-mail your questions
European Commission
Public Health
Accessibility tools
Service tools
Language selector
- Current languageen
Navigation path
- European Commission
- Public health
- Reference documents
- Register
- Orphan products
- Soluble yeast beta-1,3/1,6-glucan
Pharmaceuticals - Community Register
Community register of orphan medicinal products | GRANTED |
Product information |
Soluble yeast beta-1,3/1,6-glucan
| EU orphan designation number: | EU/3/05/294
|
| Active ingredient: | Soluble yeast beta-1,3/1,6-glucan |
| Indication: | Prevention of oral mucositis in head and neck cancer patients undergoing radiation therapy |
| Sponsor: | Biotec Pharmacon ASA
Strandgata 3, N-9008 Tromso, Norge |
Public summary of scientific opinion
European Commission procedures |
| Close date procedure | Procedure type | EMEA number | Decision | summary publ | decision docs | annex |
| 20/06/2005 | Orphan designation | EMEA/OD/005/05 | (2005)1882 of 16/06/2005 |
CONTACT
EU links
Directorate General Health & Consumers